Determination of antifungal activities in serum samples from mice treated with different antifungal drugs allows detection of an active metabolite of itraconazole

Microbiology and Immunology
K MakiSeitaro Mutoh

Abstract

To establish an in vitro method of predicting in vivo efficacy of antifungal drugs against Candida albicans and Aspergillus fumigatus, the antifungal activities of fluconazole, itraconazole, and amphotericin B were determined in mouse serum. The minimum inhibitory concentration (MIC) of each drug was measured using mouse serum as a diluent. For C. albicans, the assay endpoint of azoles was defined as inhibition of mycelial extension (mMIC) and for A. fumigatus, as no growth (MIC). The MICs of amphotericin B for both pathogens were defined as the MIC at which no mycelial growth occurred. Serum MIC or mMIC determinations were then used to estimate the concentration of the drugs in serum of mice treated with antifungal drugs by multiplying the antifungal titer of the serum samples by the serum (m)MIC. The serum drug concentrations were also determined by HPLC. The serum concentrations estimated microbiologically showed good agreement with those determined by HPLC, except for itraconazole. Analysis of the serum samples from itraconazole-treated mice by a sensitive bioautography revealed the presence of additional spots, not seen in control samples of itraconazole. The bioautography assay demonstrated that the additional material de...Continue Reading

References

Mar 1, 1977·The Journal of Infectious Diseases·I Nilsson-EhleL B Guze
Jan 1, 1989·Mycoses·J HeykantsG Cauwenbergh
Dec 1, 1988·The Journal of Antibiotics·H SakamotoS Kuwahara
Jul 1, 1994·Antimicrobial Agents and Chemotherapy·D LawD W Denning
Oct 1, 1993·Clinical Microbiology Reviews·J H RexJ N Galgiani
May 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M A PfallerM G Rinaldi
Sep 19, 2000·Antimicrobial Agents and Chemotherapy·K W HenryT D Edlind
May 17, 2001·Antimicrobial Agents and Chemotherapy·M D De BackerH Vanden Bossche
Aug 2, 2001·The Journal of Antimicrobial Chemotherapy·B RambaliF C Odds
Oct 5, 2001·Clinical Microbiology Reviews·J H RexD W Warnock
Oct 6, 2001·Current Opinion in Microbiology·J S Tkacz, B DiDomenico
Feb 16, 2002·Biologicals : Journal of the International Association of Biological Standardization·Shingo NiimiTakao Hayakawa
Jun 1, 2002·The Journal of Antimicrobial Chemotherapy·Liang ZhangJing Cheng
Jun 29, 2002·Diagnostic Microbiology and Infectious Disease·Sevtap Arikan, Gülşen Hasçelik
Jan 15, 2003·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hideyo YamaguchiToshiyuki Matsunaga
Oct 11, 2003·Lancet·David W Denning
Dec 4, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Jia Woei WongKah Hay Yuen
Dec 10, 2003·Journal of Clinical Microbiology·Alexander ImhofKieren A Marr
Jan 30, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J A Maertens
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·D T A Te DorsthorstP E Verweij
Sep 25, 2004·Antimicrobial Agents and Chemotherapy·John E ConteElisabeth Zurlinden

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.